[1]
Malik, T. et al. 2023. Short-Term Efficacy and Safety of Subcutaneous Tocilizumab in Rheumatoid Arthritis Patients in Pakistan: A Real-World Experience. Pakistan Armed Forces Medical Journal. 73, 3 (Jun. 2023), 845–49. DOI:https://doi.org/10.51253/pafmj.v73i3.7266.